Fifth Third Wealth Advisors LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1899030
Cincinnati, OH
Position in NBIX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$575,395
+$106,006 QoQ
Shares Held
3,414
-4.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#455
of 768 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fifth Third Wealth Advisors LLC holds $4,635,391 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
37,680 | $2,707,684 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,414 | $575,395 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
13,882 | $481,288 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
14,103 | $347,074 | |
| 5 | ALKS |
Alkermes plc.
|
5,454 | $285,762 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,147 | $238,188 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $575,395 | 3,414 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $469,389 | 3,563 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $444,353 | 3,133 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $439,810 | 3,133 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $392,655 | 3,124 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $352,924 | 3,191 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $434,206 | 3,181 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $366,514 | 3,181 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $434,624 | 3,157 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||